Traing Source
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
01/12/2018 $15.90 $15.95 $15.45 $15.70 364.10K
01/16/2018 $15.85 $15.90 $14.75 $14.85 646.50K
01/17/2018 $15.00 $15.55 $14.85 $15.25 590.50K
01/18/2018 $15.25 $15.40 $14.55 $14.55 432.10K
01/19/2018 $14.65 $14.93 $14.25 $14.60 415.60K
Abeona Therapeutics is a clinical stage biopharmaceutical company developing gene therapies for life-threatening rare genetic diseases. Co.'s primary programs are ABO-102 and ABO-101, adeno-associated virus based gene therapies for Sanfilippo syndrome. Co. also develops EB-101, gene-corrected skin grafts for recessive dystrophic epidermolysis bullosa; EB-201 for epidermolysis bullosa; ABO-201, gene therapy for juvenile Batten disease; ABO-202 gene therapy for treatment of infantile Batten disease; ABO-301 for Fanconi anemia disorder; and ABO-302 for rare blood diseases. Co. has a plasma-based protein therapy platform, using its proprietary SDFTM (Salt Diafiltration) ethanol-free process.
ABEO historical stock prices picture
Abeona Therapeutics (ABEO) has the following price history information. Looking back at ABEO historical stock prices for the last five trading days, on January 12, 2018, ABEO opened at $15.90, traded as high as $15.95 and as low as $15.45, and closed at $15.70. Trading volume was a total of 364.10K shares. On January 16, 2018, ABEO opened at $15.85, traded as high as $15.90 and as low as $14.75, and closed at $14.85. Trading volume was a total of 646.50K shares. On January 17, 2018, ABEO opened at $15.00, traded as high as $15.55 and as low as $14.85, and closed at $15.25. Trading volume was a total of 590.50K shares. On January 18, 2018, ABEO opened at $15.25, traded as high as $15.40 and as low as $14.55, and closed at $14.55. Trading volume was a total of 432.10K shares. On January 19, 2018, ABEO opened at $14.65, traded as high as $14.93 and as low as $14.25, and closed at $14.60. Trading volume was a total of 415.60K shares.

ABEO Historical Stock Prices By Date:

ABEO historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Abeona Therapeutics shares, starting with a $10,000 purchase of ABEO, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 01/22/2008
End date: 01/19/2018
Start price/share: $2.30
End price/share: $14.60
Dividends collected/share: $0.00
Total return: 534.78%
Average Annual Total Return: 20.30%
Starting investment: $10,000.00
Ending investment: $63,482.83
Years: 10.00
Date Close
01/12/2018$15.70
01/16/2018$14.85
01/17/2018$15.25
01/18/2018$14.55
01/19/2018$14.60
ABEO is categorized under the Healthcare sector; below are some other companies in the same sector:

ABIO Historical Stock Prices
ABLX Historical Stock Prices
ABMD Historical Stock Prices
ABT Historical Stock Prices
ABUS Historical Stock Prices
ACAD Historical Stock Prices
ACER Historical Stock Prices
ACET Historical Stock Prices
ACHC Historical Stock Prices
ACHN Historical Stock Prices

ABEO Historical Stock Prices | | Copyright © 2013 - 2018, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following . Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; , and .